@article{ART002615906},
author={Khalid Ali Khan and Rashid Ali khan and Mohammad Zakir},
title={MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW},
journal={CELLMED},
issn={3022-6805},
year={2020},
volume={10},
number={3},
pages={19-19},
doi={10.5667/CellMed.2020.0019}
TY - JOUR
AU - Khalid Ali Khan
AU - Rashid Ali khan
AU - Mohammad Zakir
TI - MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW
JO - CELLMED
PY - 2020
VL - 10
IS - 3
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 19
EP - 19
SN - 3022-6805
AB - The kidneys are exposed to toxicants and waste product and can be affected easily by these toxicants and by products of the metabolism. The consumption of adequate water is necessary to remove waste and to keep kidney healthy. Deficiency of liquid in the blood leads to various adverse effects on the kidney. The most common adverse deficiency of liquid in blood is deposition of solid matter in the kidney and subsequently formation of kidney stone. Nephrolithiasis (kidney stone) can be treated by drugs if it is small in size but if it blocks the route due to its big size then surgery is the only way to remove it. The recurrence rate of the problem is very high and it may reappear within 10 years. In Unani literature Hasāh wa Raml al-Kulya (nephrolithiasis) is described in detail. As per Unani literature stagnation of Ghalīz mādda (filthy and viscous matter) in the kidney is the main cause of the formation of kidney stone. Various single and compound formulations drugs are described for the management of kidney stone which are very effective as well as safe. Management is divided into two parts i.e. symptomatic treatment to relieve pain and to methods adopted to remove stone from the kidney. Musakkin-i-Waja‘(analgesic) drugs are used for pain while Mufattit-i-Hasāh (lithotriptic) and Mudirr-i-Bawl (Diuretic) drugs are used to remove stone. Majoon Aqrab, Qurs Kaknaj and Dawa-e-Gurda etc. are compound drugs mentioned in literature for removal of kidney stone. Single drugs like Alu Balu, Tukhm Khayar, and Kharkhask etc. are also used for same purpose.
KW - Cystolithiasis;Hasah wa Raml;Jarahat;Nephrolithiasis;Unani
DO - 10.5667/CellMed.2020.0019
ER -
Khalid Ali Khan, Rashid Ali khan and Mohammad Zakir. (2020). MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW. CELLMED, 10(3), 19-19.
Khalid Ali Khan, Rashid Ali khan and Mohammad Zakir. 2020, "MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW", CELLMED, vol.10, no.3 pp.19-19. Available from: doi:10.5667/CellMed.2020.0019
Khalid Ali Khan, Rashid Ali khan, Mohammad Zakir "MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW" CELLMED 10.3 pp.19-19 (2020) : 19.
Khalid Ali Khan, Rashid Ali khan, Mohammad Zakir. MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW. 2020; 10(3), 19-19. Available from: doi:10.5667/CellMed.2020.0019
Khalid Ali Khan, Rashid Ali khan and Mohammad Zakir. "MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW" CELLMED 10, no.3 (2020) : 19-19.doi: 10.5667/CellMed.2020.0019
Khalid Ali Khan; Rashid Ali khan; Mohammad Zakir. MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW. CELLMED, 10(3), 19-19. doi: 10.5667/CellMed.2020.0019
Khalid Ali Khan; Rashid Ali khan; Mohammad Zakir. MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW. CELLMED. 2020; 10(3) 19-19. doi: 10.5667/CellMed.2020.0019
Khalid Ali Khan, Rashid Ali khan, Mohammad Zakir. MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW. 2020; 10(3), 19-19. Available from: doi:10.5667/CellMed.2020.0019
Khalid Ali Khan, Rashid Ali khan and Mohammad Zakir. "MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW" CELLMED 10, no.3 (2020) : 19-19.doi: 10.5667/CellMed.2020.0019